These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29443984)

  • 1. Synthetic biology: Reframing cell therapy for cancer.
    Dolberg TB; Donahue PS; Leonard JN
    Nat Chem Biol; 2018 Feb; 14(3):204-205. PubMed ID: 29443984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modular design of synthetic receptors for programmed gene regulation in cell therapies.
    Zhu I; Liu R; Garcia JM; Hyrenius-Wittsten A; Piraner DI; Alavi J; Israni DV; Liu B; Khalil AS; Roybal KT
    Cell; 2022 Apr; 185(8):1431-1443.e16. PubMed ID: 35427499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic cells: emerging clinical applications of synthetic biology.
    McNerney MP; Doiron KE; Ng TL; Chang TZ; Silver PA
    Nat Rev Genet; 2021 Nov; 22(11):730-746. PubMed ID: 34234299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.
    Rath JA; Arber C
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
    Chang ZL; Chen YY
    Trends Mol Med; 2017 May; 23(5):430-450. PubMed ID: 28416139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell therapy's poster child: Chimeric antigen receptor T cell therapy].
    Qian L; Chen J; Wu X; Jing R; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2339-2349. PubMed ID: 31880140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer.
    Melenhorst JJ; Lacey SF; Bedoya F
    Curr Drug Targets; 2017; 18(3):332-340. PubMed ID: 26302796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward synthetic biology with engineered T cells: a long journey just begun.
    June CH
    Hum Gene Ther; 2014 Sep; 25(9):779-84. PubMed ID: 25244569
    [No Abstract]   [Full Text] [Related]  

  • 9. Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.
    Esensten JH; Bluestone JA; Lim WA
    Annu Rev Pathol; 2017 Jan; 12():305-330. PubMed ID: 27959633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic biology in cell-based cancer immunotherapy.
    Chakravarti D; Wong WW
    Trends Biotechnol; 2015 Aug; 33(8):449-61. PubMed ID: 26088008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell engineering as therapy for cancer and HIV: our synthetic future.
    June CH; Levine BL
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140374. PubMed ID: 26416683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control.
    Lu L; Xie M; Yang B; Zhao WB; Cao J
    Sci Adv; 2024 Feb; 10(8):eadj6251. PubMed ID: 38394207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.
    Rivière I; Sadelain M
    Mol Ther; 2017 May; 25(5):1117-1124. PubMed ID: 28456379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies.
    Kiesgen S; Chicaybam L; Chintala NK; Adusumilli PS
    J Thorac Oncol; 2018 Jan; 13(1):16-26. PubMed ID: 29107016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic biology: at the crossroads of genetic engineering and human therapeutics-a Keystone Symposia report.
    Cable J; Leonard JN; Lu TK; Xie Z; Chang MW; Fernández LÁ; Lora JM; Kaufman HL; Quintana FJ; Geiger R; F Lesser C; Lynch JP; Hava DL; Cornish VW; Lee GK; DiAndreth B; Fero M; Srivastava R; De Coster T; Roybal KT; Rackham OJL; Kiani S; Zhu I; Hernandez-Lopez RA; Guo T; Chen WCW
    Ann N Y Acad Sci; 2021 Dec; 1506(1):98-117. PubMed ID: 34786712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.
    Kalos M; June CH
    Immunity; 2013 Jul; 39(1):49-60. PubMed ID: 23890063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Biology: Immunotherapy by Design.
    Brenner J; Cho JH; Wong NML; Wong WW
    Annu Rev Biomed Eng; 2018 Jun; 20():95-118. PubMed ID: 29345976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Principles of Engineering Immune Cells to Treat Cancer.
    Lim WA; June CH
    Cell; 2017 Feb; 168(4):724-740. PubMed ID: 28187291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Chimeric Antigen Receptor T-Cell Therapy Approved.
    Brower V
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29106609
    [No Abstract]   [Full Text] [Related]  

  • 20. Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.
    Feldman SA; Assadipour Y; Kriley I; Goff SL; Rosenberg SA
    Semin Oncol; 2015 Aug; 42(4):626-39. PubMed ID: 26320066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.